Web NewDrugInformation.com

Dextrose 5% In Acetated Ringer's In Plastic Container Drug - Dextrose 5% In Acetated Ringer's In Plastic Container The trade name of the product as shown on the labeling. Dosage - INJECTABLE; INJECTION The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Calcium Chloride; Dextrose; Potassium Chloride; Sodium Acetate; Sodium Chloride Multiple ingredients are in alphabetical order. Strength - 20MG/100ML;5GM/100ML;30MG/100ML;380MG/100ML;600MG/100ML The potency of the active ingredient(s), Calcium Chloride; Dextrose; Potassium Chloride; Sodium Acetate; Sodium Chloride. May repeat for multiple part products. Applicant - B BRAUN The firm name holding legal responsibility for Dextrose 5% In Acetated Ringer's In Plastic Container. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 018258 The FDA assigned number to Dextrose 5% In Acetated Ringer's In Plastic Container. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify Dextrose 5% In Acetated Ringer's In Plastic Container. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Approved Prior to Jan 1, 1982 The date Dextrose 5% In Acetated Ringer's In Plastic Container was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - No The pioneer or innovator of Dextrose 5% In Acetated Ringer's In Plastic Container. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - RX The group or category of approved drugs Dextrose 5% In Acetated Ringer's In Plastic Container is in. Format is RX, OTC, DISCN. Applicant Full Name - B Braun Medical Inc The full name of the firm holding legal responsibility for the new application of Dextrose 5% In Acetated Ringer's In Plastic Container. Dextrose 5% In Acetated Ringer's In Plastic Container Dianeal Pd-2 W/ Dextrose 4.25% In Plastic Container 25.7mg/100ml;4.25gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Inpersol-lc/lm W/ Dextrose 1.5% In Plastic Container 18.4mg/100ml;1.5gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Inpersol-lc/lm W/ Dextrose 2.5% In Plastic Container 18.4mg/100ml;2.5gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Inpersol-lc/lm W/ Dextrose 3.5% In Plastic Container 18.4mg/100ml;3.5gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Inpersol-lc/lm W/ Dextrose 4.25% In Plastic Container 18.4mg/100ml;4.25gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Elliotts B Solution 0.2mg/ml;0.8mg/ml;0.3mg/ml;0.3mg/ml;1.9mg/ml;7.3mg/ml;0.2mg/ml Injectable; Intrathecal Dextrose 5% In Acetated Ringer's In Plastic Container 20mg/100ml;5gm/100ml;30mg/100ml;380mg/100ml;600mg/100ml Injectable; Injection Dianeal Pd-2 W/ Dextrose 2.5% In Plastic Container 25.7mg/100ml;2.5gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Dianeal Pd-2 W/ Dextrose 3.5% In Plastic Container 25.7mg/100ml;3.5gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Dianeal Pd-2 W/ Dextrose 4.25% In Plastic Container 25.7mg/100ml;4.25gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal NewDrugInformation